PTC Therapeutics, Inc. (PTCT)
NASDAQ: PTCT · Real-Time Price · USD
39.60
-1.05 (-2.58%)
May 6, 2025, 12:18 PM EDT - Market open
PTC Therapeutics Analyst Ratings
Total Analysts
13
Consensus Rating
Buy
Price Target
$63.92
Upside
+61.41%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Reiterates $65 | Buy | Reiterates | $65 | +64.14% | Apr 22, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $78 → $75 | Buy | Maintains | $78 → $75 | +89.39% | Mar 31, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $72 → $78 | Buy | Maintains | $72 → $78 | +96.97% | Mar 14, 2025 |
| B of A Securities | B of A Securities | Sell → Hold Upgrades $41 → $55 | Sell → Hold | Upgrades | $41 → $55 | +38.89% | Mar 11, 2025 |
| Scotiabank | Scotiabank | Hold Initiates $55 | Hold | Initiates | $55 | +38.89% | Mar 7, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $67 → $70 | Buy | Initiates | $67 → $70 | +76.77% | Mar 7, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $74 → $72 | Buy | Maintains | $74 → $72 | +81.82% | Feb 28, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $60 → $63 | Buy | Maintains | $60 → $63 | +59.09% | Feb 18, 2025 |
| Citigroup | Citigroup | Strong Sell Maintains $32 → $45 | Strong Sell | Maintains | $32 → $45 | +13.64% | Feb 12, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $76 → $113 | Buy | Maintains | $76 → $113 | +185.35% | Feb 3, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $80 → $76 | Buy | Maintains | $80 → $76 | +91.92% | Jan 15, 2025 |
| Morgan Stanley | Morgan Stanley | Hold → Buy Upgrades $45 → $67 | Hold → Buy | Upgrades | $45 → $67 | +69.19% | Dec 13, 2024 |
| Citigroup | Citigroup | Strong Sell Maintains $26 → $32 | Strong Sell | Maintains | $26 → $32 | -19.19% | Dec 4, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Sell Maintains $32 → $42 | Strong Sell | Maintains | $32 → $42 | +6.06% | Dec 4, 2024 |
| UBS | UBS | Strong Buy Maintains $47 → $71 | Strong Buy | Maintains | $47 → $71 | +79.29% | Dec 3, 2024 |
| Baird | Baird | Buy Maintains $52 → $70 | Buy | Maintains | $52 → $70 | +76.77% | Dec 3, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.